June 21, 2024Open Access

Phage Therapy: An Alternative Approach to Combat Multi-drug Resistant Infections in Cystic Fibrosis

MCMario CocorulloUniversity of Pavia GSGiovanni StelitanoUniversity of Pavia LCLaurent R. ChiarelliUniversity of Pavia

Key Points

Key points are not available for this paper at this time.

Abstract

In this review we aim to address the current status of phage therapy in the management of multidrug-resistant infections, from compassionate use cases to ongoing clinical trials, as well as the challenges this approach presents in the particular context of CF patients.

Ask AI

Helpful

Bookmark

View Full Paper

Cite This Study

Cocorullo et al. (Fri,) studied this question.

synapsesocial.com/papers/68e63c23b6db6435875ce5ea https://doi.org/https://doi.org/10.20944/preprints202406.1446.v1

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Synergistic bactericidal effects of phage-enhanced antibiotic therapy against MRSA biofilms2024 · 25 citations
2Safety and microbiological activity of phage therapy in persons with cystic fibrosis colonized with Pseudomonas aeruginosa: study protocol for a phase 1b/2, multicenter, randomized, double-blind, placebo-controlled trial2022 · 64 citations
3Antibiotic resistance in Pseudomonas aeruginosa – Mechanisms, epidemiology and evolution2019 · 549 citations
4Successful adjunctive use of bacteriophage therapy for treatment of multidrug-resistant Pseudomonas aeruginosa infection in a cystic fibrosis patient2019 · 265 citations
5Phage Therapy in the Postantibiotic Era2019 · 990 citations

Ask AI

Helpful

Bookmark

View Full Paper